Item Type | Name |
Concept
|
Hypertension
|
Concept
|
Hypertension, Portal
|
Concept
|
Hypertension, Pulmonary
|
Academic Article
|
Nebulized nitric oxide/nucleophile adduct reduces chronic pulmonary hypertension.
|
Academic Article
|
Chronic infusion of nitric oxide in experimental pulmonary hypertension: pulmonary pressure-flow analysis.
|
Academic Article
|
A placebo-controlled trial of prostacyclin in acute respiratory failure in COPD.
|
Academic Article
|
The somatostatin analog angiopeptin does not reduce chronic hypoxic pulmonary hypertension in rats.
|
Academic Article
|
Aerosol delivery of diethylenetriamine/nitric oxide, a nitric oxide adduct, causes selective pulmonary vasodilation in perinatal lambs.
|
Academic Article
|
Pulmonary vasoconstriction, oxygen sensing, and the role of ion channels: Thomas A. Neff lecture.
|
Academic Article
|
Nitric oxide deficiency in fenfluramine- and dexfenfluramine-induced pulmonary hypertension.
|
Academic Article
|
Dichloroacetate, a metabolic modulator, prevents and reverses chronic hypoxic pulmonary hypertension in rats: role of increased expression and activity of voltage-gated potassium channels.
|
Academic Article
|
Primary pulmonary hypertension: a vascular biology and translational research "Work in progress".
|
Academic Article
|
Case 2. Recurrence of myocardial infarction.
|
Academic Article
|
Gene transfer and metabolic modulators as new therapies for pulmonary hypertension. Increasing expression and activity of potassium channels in rat and human models.
|
Academic Article
|
In vivo gene transfer of the O2-sensitive potassium channel Kv1.5 reduces pulmonary hypertension and restores hypoxic pulmonary vasoconstriction in chronically hypoxic rats.
|
Academic Article
|
Cellular and molecular pathobiology of pulmonary arterial hypertension.
|
Academic Article
|
Oral sildenafil is an effective and specific pulmonary vasodilator in patients with pulmonary arterial hypertension: comparison with inhaled nitric oxide.
|
Academic Article
|
Long-term treatment with oral sildenafil is safe and improves functional capacity and hemodynamics in patients with pulmonary arterial hypertension.
|
Academic Article
|
Canadian Cardiovascular Society and Canadian Thoracic Society position statement on pulmonary arterial hypertension.
|
Academic Article
|
Acute oxygen-sensing mechanisms.
|
Academic Article
|
An evidence-based approach to the management of pulmonary arterial hypertension.
|
Academic Article
|
Canadian Cardiovascular Society and Canadian Thoracic Society position statement on pulmonary arterial hypertension.
|
Academic Article
|
The NO - K+ channel axis in pulmonary arterial hypertension. Activation by experimental oral therapies.
|
Academic Article
|
An abnormal mitochondrial-hypoxia inducible factor-1alpha-Kv channel pathway disrupts oxygen sensing and triggers pulmonary arterial hypertension in fawn hooded rats: similarities to human pulmonary arterial hypertension.
|
Academic Article
|
Overexpression of human bone morphogenetic protein receptor 2 does not ameliorate monocrotaline pulmonary arterial hypertension.
|
Academic Article
|
The role of k+ channels in determining pulmonary vascular tone, oxygen sensing, cell proliferation, and apoptosis: implications in hypoxic pulmonary vasoconstriction and pulmonary arterial hypertension.
|
Academic Article
|
Potassium channel diversity in the pulmonary arteries and pulmonary veins: implications for regulation of the pulmonary vasculature in health and during pulmonary hypertension.
|
Academic Article
|
The nuclear factor of activated T cells in pulmonary arterial hypertension can be therapeutically targeted.
|
Academic Article
|
ZK 36-374, a stable analog of prostacyclin, prevents acute hypoxic pulmonary hypertension in the dog.
|
Academic Article
|
Carbon monoxide diffusing capacity and mortality in pulmonary arterial hypertension.
|
Academic Article
|
Phosphodiesterase type 5 inhibitors for pulmonary arterial hypertension.
|
Academic Article
|
Survival in pulmonary arterial hypertension: a reappraisal of the NIH risk stratification equation.
|
Academic Article
|
A dosing/cross-development study of the multikinase inhibitor sorafenib in patients with pulmonary arterial hypertension.
|
Academic Article
|
Basic science of pulmonary arterial hypertension for clinicians: new concepts and experimental therapies.
|
Academic Article
|
Diagnosis and management of pulmonary hypertension in systemic sclerosis.
|
Academic Article
|
Validation of high-resolution echocardiography and magnetic resonance imaging vs. high-fidelity catheterization in experimental pulmonary hypertension.
|
Academic Article
|
Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association.
|
Academic Article
|
Long-term effects of epoprostenol on the pulmonary vasculature in idiopathic pulmonary arterial hypertension.
|
Academic Article
|
ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association.
|
Academic Article
|
Antenatal sildenafil treatment attenuates pulmonary hypertension in experimental congenital diaphragmatic hernia.
|
Academic Article
|
Rodent models of pulmonary hypertension: harmonisation with the world health organisation's categorisation of human PH.
|
Academic Article
|
Lung ¹8F-fluorodeoxyglucose positron emission tomography for diagnosis and monitoring of pulmonary arterial hypertension.
|
Academic Article
|
Association of serum creatinine with abnormal hemodynamics and mortality in pulmonary arterial hypertension.
|
Academic Article
|
Paracrine proliferative signaling by senescent cells in world health organization group 3 pulmonary hypertension: age corrupting youth?
|
Academic Article
|
Chronic primary and secondary thromboembolic pulmonary hypertension.
|
Academic Article
|
Gene therapy targeting survivin selectively induces pulmonary vascular apoptosis and reverses pulmonary arterial hypertension.
|
Academic Article
|
Pulmonary endarterectomy surgery--a technically demanding cure for WHO Group IV Pulmonary Hypertension: requirements for centres of excellence and availability in Canada.
|
Academic Article
|
Chronic EDRF inhibition and hypoxia: effects on pulmonary circulation and systemic blood pressure.
|
Academic Article
|
Airway delivery of mesenchymal stem cells prevents arrested alveolar growth in neonatal lung injury in rats.
|
Academic Article
|
Value of exercise treadmill testing in the risk stratification of patients with pulmonary hypertension.
|
Academic Article
|
Epigenetic attenuation of mitochondrial superoxide dismutase 2 in pulmonary arterial hypertension: a basis for excessive cell proliferation and a new therapeutic target.
|
Academic Article
|
Dynamin-related protein 1-mediated mitochondrial mitotic fission permits hyperproliferation of vascular smooth muscle cells and offers a novel therapeutic target in pulmonary hypertension.
|
Academic Article
|
The WHO classification of pulmonary hypertension: A case-based imaging compendium.
|
Academic Article
|
Evolving epidemiology of pulmonary arterial hypertension.
|
Academic Article
|
Comparison of the hemodynamic effects of nitric oxide and endothelium-dependent vasodilators in intact lungs.
|
Academic Article
|
Increased endothelium-derived NO in hypertensive pulmonary circulation of chronically hypoxic rats.
|
Academic Article
|
Comparative effects of nisoldipine, nifedipine and bepridil on experimental pulmonary hypertension.
|
Academic Article
|
Statin therapy, alone or with rapamycin, does not reverse monocrotaline pulmonary arterial hypertension: the rapamcyin-atorvastatin-simvastatin study.
|
Academic Article
|
Chronic hypoxic pulmonary hypertension. Is thrombin involved?
|
Academic Article
|
Cellular and molecular basis of pulmonary arterial hypertension.
|
Academic Article
|
Effect of dietary fish oil on lung lipid profile and hypoxic pulmonary hypertension.
|
Academic Article
|
Late gadolinium enhancement cardiovascular magnetic resonance predicts clinical worsening in patients with pulmonary hypertension.
|
Academic Article
|
Anorexic agents aminorex, fenfluramine, and dexfenfluramine inhibit potassium current in rat pulmonary vascular smooth muscle and cause pulmonary vasoconstriction.
|
Academic Article
|
A role for potassium channels in smooth muscle cells and platelets in the etiology of primary pulmonary hypertension.
|
Academic Article
|
Pulmonary arterial hypertension: future directions: report of a National Heart, Lung and Blood Institute/Office of Rare Diseases workshop.
|
Academic Article
|
Hypoxic pulmonary vasoconstriction.
|
Academic Article
|
Mitochondrial metabolism, redox signaling, and fusion: a mitochondria-ROS-HIF-1alpha-Kv1.5 O2-sensing pathway at the intersection of pulmonary hypertension and cancer.
|
Academic Article
|
ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association.
|
Academic Article
|
A proposed mitochondrial-metabolic mechanism for initiation and maintenance of pulmonary arterial hypertension in fawn-hooded rats: the Warburg model of pulmonary arterial hypertension.
|
Academic Article
|
Epigenetic mechanisms of pulmonary hypertension.
|
Academic Article
|
PGC1a-mediated mitofusin-2 deficiency in female rats and humans with pulmonary arterial hypertension.
|
Academic Article
|
QTc prolongation is associated with impaired right ventricular function and predicts mortality in pulmonary hypertension.
|
Academic Article
|
Metabolism and bioenergetics in the right ventricle and pulmonary vasculature in pulmonary hypertension.
|
Academic Article
|
FOXO1-mediated upregulation of pyruvate dehydrogenase kinase-4 (PDK4) decreases glucose oxidation and impairs right ventricular function in pulmonary hypertension: therapeutic benefits of dichloroacetate.
|
Academic Article
|
GRK2-mediated inhibition of adrenergic and dopaminergic signaling in right ventricular hypertrophy: therapeutic implications in pulmonary hypertension.
|
Academic Article
|
Cardiac glutaminolysis: a maladaptive cancer metabolism pathway in the right ventricle in pulmonary hypertension.
|
Academic Article
|
Persistence of complex vascular lesions despite prolonged prostacyclin therapy of pulmonary arterial hypertension.
|
Academic Article
|
Noninvasive cardiac output measurements in patients with pulmonary hypertension.
|
Academic Article
|
Ischemia-induced Drp1 and Fis1-mediated mitochondrial fission and right ventricular dysfunction in pulmonary hypertension.
|
Academic Article
|
Increased Drp1-Mediated Mitochondrial Fission Promotes Proliferation and Collagen Production by Right Ventricular Fibroblasts in Experimental Pulmonary Arterial Hypertension.
|
Academic Article
|
A pro-con debate: current controversies in PAH pathogenesis at the American Thoracic Society International Conference in 2017.
|
Academic Article
|
Acquired Mitochondrial Abnormalities, Including Epigenetic Inhibition of Superoxide Dismutase 2, in Pulmonary Hypertension and Cancer: Therapeutic Implications.
|
Academic Article
|
Pulmonary pulse wave transit time is associated with right ventricular-pulmonary artery coupling in pulmonary arterial hypertension.
|
Academic Article
|
Soluble guanylate cyclase: a new therapeutic target for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.
|
Academic Article
|
Survival in pulmonary hypertension due to chronic lung disease: Influence of low diffusion capacity of the lungs for carbon monoxide.
|
Academic Article
|
Pulmonary arterial hypertension: pathogenesis and clinical management.
|
Academic Article
|
Transcriptomic Signature of Right Ventricular Failure in Experimental Pulmonary Arterial Hypertension: Deep Sequencing Demonstrates Mitochondrial, Fibrotic, Inflammatory and Angiogenic Abnormalities.
|
Academic Article
|
Trends and Outcomes of Pulmonary Arterial Hypertension-Related Hospitalizations in the United States: Analysis of the Nationwide Inpatient Sample Database From 2001 Through 2012.
|
Academic Article
|
Disproportionate Right Ventricular Dysfunction and Poor Survival in Group 3 Pulmonary Hypertension.
|
Academic Article
|
Interleukin-6 is independently associated with right ventricular function in pulmonary arterial hypertension.
|
Academic Article
|
Riociguat for pulmonary hypertension--a glass half full.
|
Academic Article
|
Epigenetic Dysregulation of the Dynamin-Related Protein 1 Binding Partners MiD49 and MiD51 Increases Mitotic Mitochondrial Fission and Promotes Pulmonary Arterial Hypertension: Mechanistic and Therapeutic Implications.
|
Academic Article
|
Rodent models of group 1 pulmonary hypertension.
|
Academic Article
|
Critical Genomic Networks and Vasoreactive Variants in Idiopathic Pulmonary Arterial Hypertension.
|
Academic Article
|
Emerging concepts in the molecular basis of pulmonary arterial hypertension: part I: metabolic plasticity and mitochondrial dynamics in the pulmonary circulation and right ventricle in pulmonary arterial hypertension.
|
Academic Article
|
Anticipated classes of new medications and molecular targets for pulmonary arterial hypertension.
|
Academic Article
|
An official American Thoracic Society Statement: pulmonary hypertension phenotypes.
|
Academic Article
|
The right ventricle in pulmonary arterial hypertension: disorders of metabolism, angiogenesis and adrenergic signaling in right ventricular failure.
|
Academic Article
|
Executive Summary of the American Heart Association and American Thoracic Society Joint Guidelines for Pediatric Pulmonary Hypertension.
|
Academic Article
|
Colchicine Depolymerizes Microtubules, Increases Junctophilin-2, and Improves Right Ventricular Function in Experimental Pulmonary Arterial Hypertension.
|
Academic Article
|
[Relevant issues in the pathology and pathobiology of pulmonary hypertension].
|
Academic Article
|
MicroRNA-138 and MicroRNA-25 Down-regulate Mitochondrial Calcium Uniporter, Causing the Pulmonary Arterial Hypertension Cancer Phenotype.
|
Academic Article
|
Right ventricular adaptation and failure in pulmonary arterial hypertension.
|
Academic Article
|
Pediatric Pulmonary Hypertension: Guidelines From the American Heart Association and American Thoracic Society.
|
Academic Article
|
Mitochondrial dynamics in pulmonary arterial hypertension.
|
Academic Article
|
Standards and Methodological Rigor in Pulmonary Arterial Hypertension Preclinical and Translational Research.
|
Academic Article
|
Models and Molecular Mechanisms of World Health Organization Group 2 to 4 Pulmonary Hypertension.
|
Academic Article
|
Peripheral blood signature of vasodilator-responsive pulmonary arterial hypertension.
|
Academic Article
|
Pyruvate Kinase and Warburg Metabolism in Pulmonary Arterial Hypertension: Uncoupled Glycolysis and the Cancer-Like Phenotype of Pulmonary Arterial Hypertension.
|
Academic Article
|
Pulmonary hypertension begets pulmonary hypertension: mutually reinforcing roles for haemodynamics, inflammation, and cancer-like phenotypes.
|
Academic Article
|
Relevant issues in the pathology and pathobiology of pulmonary hypertension.
|
Academic Article
|
Increasing Incidence and Prevalence of World Health Organization Groups 1 to 4 Pulmonary Hypertension: A Population-Based Cohort Study in Ontario, Canada.
|
Academic Article
|
A Step Closer to Understanding How Riociguat Results in Remodelling of the Right Ventricle in Chronic Thromboembolic Pulmonary Hypertension.
|
Academic Article
|
Genetic determinants of risk in pulmonary arterial hypertension: international genome-wide association studies and meta-analysis.
|
Academic Article
|
Repurposing Medications for Treatment of Pulmonary Arterial Hypertension: What's Old Is New Again.
|
Academic Article
|
Clinical Determinants and Prognostic Implications of Right Ventricular Dysfunction in Pulmonary Hypertension Caused by Chronic Lung Disease.
|
Academic Article
|
Pathophysiology, incidence, management, and consequences of cardiac arrhythmia in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.
|
Academic Article
|
Biventricular Increases in Mitochondrial Fission Mediator (MiD51) and Proglycolytic Pyruvate Kinase (PKM2) Isoform in Experimental Group 2 Pulmonary Hypertension-Novel Mitochondrial Abnormalities.
|
Academic Article
|
Left Atrial Stenosis Induced Pulmonary Venous Arterialization and Group 2 Pulmonary Hypertension in Rat.
|
Academic Article
|
Metabolic Syndrome Exacerbates Pulmonary Hypertension due to Left Heart Disease.
|
Academic Article
|
Hypochloremia Is a Noninvasive Predictor of Mortality in Pulmonary Arterial Hypertension.
|
Academic Article
|
Novel Mutations and Decreased Expression of the Epigenetic Regulator TET2 in Pulmonary Arterial Hypertension.
|
Academic Article
|
Mitochondria in the Pulmonary Vasculature in Health and Disease: Oxygen-Sensing, Metabolism, and Dynamics.
|
Academic Article
|
Epigenetic Metabolic Reprogramming of Right Ventricular Fibroblasts in Pulmonary Arterial Hypertension: A Pyruvate Dehydrogenase Kinase-Dependent Shift in Mitochondrial Metabolism Promotes Right Ventricular Fibrosis.
|
Academic Article
|
Supra-coronary aortic banding improves right ventricular function in experimental pulmonary arterial hypertension in rats by increasing systolic right coronary artery perfusion.
|
Academic Article
|
Differentiating COVID-19 Pneumonia From Acute Respiratory Distress Syndrome and High Altitude Pulmonary Edema: Therapeutic Implications.
|
Academic Article
|
Identification of Long Noncoding RNA H19 as a New Biomarker and Therapeutic Target in Right Ventricular Failure in Pulmonary Arterial Hypertension.
|
Academic Article
|
Endothelial BMPR2 Loss Drives a Proliferative Response to BMP (Bone Morphogenetic Protein) 9 via Prolonged Canonical Signaling.
|
Academic Article
|
Evaluation of the Impact of an Echocardiographic Diagnosis of Pulmonary Hypertension on Patient Outcomes.
|
Academic Article
|
Excess Protein O-GlcNAcylation Links Metabolic Derangements to Right Ventricular Dysfunction in Pulmonary Arterial Hypertension.
|
Academic Article
|
Oxygen sensing, mitochondrial biology and experimental therapeutics for pulmonary hypertension and cancer.
|
Academic Article
|
Scientist on the Spot: Exploring the cause and cure for pulmonary arterial hypertension.
|
Academic Article
|
Hemodynamic Characteristics and Outcomes of Pulmonary Hypertension in Patients Undergoing Tricuspid Valve Repair or Replacement.
|
Academic Article
|
Left Main Coronary Artery Compression in Pulmonary Arterial Hypertension: Percutaneous Treatment to Improve Symptoms.
|
Academic Article
|
Corrigendum to: Scientist on the spot: Exploring the cause and cure for pulmonary arterial hypertension.
|
Academic Article
|
Carvedilol for Treatment of Right Ventricular Dysfunction in Pulmonary Arterial Hypertension.
|
Academic Article
|
PINK1-induced phosphorylation of mitofusin 2 at serine 442 causes its proteasomal degradation and promotes cell proliferation in lung cancer and pulmonary arterial hypertension.
|
Academic Article
|
Diagnosis and Treatment of Right Heart Failure in Pulmonary Vascular Diseases: A National Heart, Lung, and Blood Institute Workshop.
|
Academic Article
|
Inflammatory Glycoprotein 130 Signaling Links Changes in Microtubules and Junctophilin-2 to Altered Mitochondrial Metabolism and Right Ventricular Contractility.
|
Academic Article
|
Inhibiting pyruvate kinase muscle isoform 2 regresses group 2 pulmonary hypertension induced by supra-coronary aortic banding.
|
Academic Article
|
Using health administrative data to identify patients with pulmonary hypertension: A single center, proof of concept validation study in Ontario, Canada.
|
Academic Article
|
Macrophage-NLRP3 Activation Promotes Right Ventricle Failure in Pulmonary Arterial Hypertension.
|
Academic Article
|
An integrated proteomic and transcriptomic signature of the failing right ventricle in monocrotaline induced pulmonary arterial hypertension in male rats.
|
Academic Article
|
Acquired disorders of mitochondrial metabolism and dynamics in pulmonary arterial hypertension.
|
Academic Article
|
Effect of Chronic Digoxin Use on Mortality and Heart Failure Hospitalization in Pulmonary Arterial Hypertension.
|
Concept
|
Familial Primary Pulmonary Hypertension
|
Grant
|
Impaired mitochondrial fusion in pulmonary arterial hypertension
|
Grant
|
EDRF IN NORMAL AND HYPERTENSIVE PULMONARY VASCULATURE
|
Grant
|
The Role of DRP-1 and Mitochondrial Fission in Pulmonary Arterial Hypertension
|
Academic Article
|
The Role of Mitochondrial Dynamics and Mitotic Fission in Regulating the Cell Cycle in Cancer and Pulmonary Arterial Hypertension: Implications for Dynamin-Related Protein 1 and Mitofusin2 in Hyperproliferative Diseases.
|
Academic Article
|
The Role of Clonal Hematopoiesis of Indeterminant Potential and DNA (Cytosine-5)-Methyltransferase Dysregulation in Pulmonary Arterial Hypertension and Other Cardiovascular Diseases.
|
Academic Article
|
Complete Revascularization of the Pulmonary Circulation in Chronic Thromboembolic Pulmonary Hypertension: Value of Addressing Chronic Total Occlusions.
|
Academic Article
|
Efficacy of Drpitor1a, a Dynamin-Related Protein 1 inhibitor, in Pulmonary Arterial Hypertension.
|
Academic Article
|
Pulmonary hypertension.
|
Academic Article
|
Germline and Somatic Mutations in DNA Methyltransferase 3A (DNMT3A) Predispose to Pulmonary Arterial Hypertension (PAH) in Humans and Mice: Implications for Associated PAH.
|